Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Hermans

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Blood|September 20, 2014
An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatmentJohn D Gibbins, Lindsay R Ancelet, Robert Weinkove, et al.
Journal of Leukocyte Biology|February 8, 2011
Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivoHelen M A Simkins, Evelyn Hyde, Kathryn J Farrand, et al.
Journal of Immunological Methods|February 12, 2004
The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivoIan F Hermans, Jonathan D Silk, Jianping Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cellsIan F Hermans, Jonathan D Silk, Uzi Gileadi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2012
Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responsesSara J McKee, Vivienne L Young, Fiona Clow, et al.
International Journal of Cancer|November 4, 2014
Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cellsAstrid Authier, Kathryn J Farrand, Kate W R Broadley, et al.
Bioconjugate Chemistry|April 6, 2023
Synthesis and Biological Evaluation of Peptide-Adjuvant Conjugate Vaccines with Increasing Antigen ContentTaylor R Cooney, Kathryn Farrand, Sarah L Draper, et al.
Pathology|January 27, 2022
Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningiomaClinton P Turner, Jessica McLay, Ian F Hermans, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Tumor immunotherapy by epicutaneous immunization requires langerhans cellsPatrizia Stoitzner, Laura K Green, Jae Y Jung, et al.
Frontiers in Pharmacology|June 24, 2021
Engineering the <i>Escherichia coli</i> Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation SystemAbigail V Sharrock, Sarah P McManaway, Michelle H Rich, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Blood|September 20, 2014
An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatmentJohn D Gibbins, Lindsay R Ancelet, Robert Weinkove, et al.
Journal of Leukocyte Biology|February 8, 2011
Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivoHelen M A Simkins, Evelyn Hyde, Kathryn J Farrand, et al.
Journal of Immunological Methods|February 12, 2004
The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivoIan F Hermans, Jonathan D Silk, Jianping Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cellsIan F Hermans, Jonathan D Silk, Uzi Gileadi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2012
Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responsesSara J McKee, Vivienne L Young, Fiona Clow, et al.
International Journal of Cancer|November 4, 2014
Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cellsAstrid Authier, Kathryn J Farrand, Kate W R Broadley, et al.
Bioconjugate Chemistry|April 6, 2023
Synthesis and Biological Evaluation of Peptide-Adjuvant Conjugate Vaccines with Increasing Antigen ContentTaylor R Cooney, Kathryn Farrand, Sarah L Draper, et al.
Pathology|January 27, 2022
Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningiomaClinton P Turner, Jessica McLay, Ian F Hermans, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Tumor immunotherapy by epicutaneous immunization requires langerhans cellsPatrizia Stoitzner, Laura K Green, Jae Y Jung, et al.
Frontiers in Pharmacology|June 24, 2021
Engineering the <i>Escherichia coli</i> Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation SystemAbigail V Sharrock, Sarah P McManaway, Michelle H Rich, et al.
Pageof 10